Association of Endodontic Infection With Cardiovascular Disease.
NCT ID: NCT03425383
Last Updated: 2018-02-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2016-11-01
2018-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Gum Infection on Heart Disease
NCT00093236
Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction (AMI)
NCT04046237
Assess the Effect of Treating Periodontal Disease on Cardiovascular Function in Young Adults
NCT01376791
Expression of Trefoil Factors and Adrenomedullin in Subjects With Chronic Periodontitis and Coronary Heart Disease
NCT04127474
Effects of Periodontal Therapy on Systemic Inflammation
NCT01046435
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Clinically, vasoregulation has been measured in both the coronary and peripheral circulation, using changes in vessel diameter as an index of conduit vessel endothelial function. The three most common clinically used techniques are-(a) Angiography, (b) Flow mediated dilatation (FMD), (c) and Venous plethysmography. Due to the invasive nature of angiography and plethysmography, these methods are unsuitable to be used on asymptomatic patients.
On the other hand, the non-invasive nature of the FMD allows repeated measurements over time to study the effectiveness of various interventions that may affect vascular health. The sensitivity and specificity of FMD is 95% and 37% respectively. Impaired endothelium-dependent dilatation in the coronary circulation is associated with coronary atherosclerosis and coronary risk factors and improves with risk reduction therapies. It has been shown FMD was an independent predictor of cardiovascular disease. Thus, brachial artery flow-mediated dilation prove useful to assess cardio- vascular risk, guide therapy, and judge the potential utility of new interventions for cardiovascular disease. FMD, which is most widely used non-invasive ultrasound method to assess endothelial function has been used in various interventional and cross-sectional studies depicting the link between periodontitis and endothelial dysfunction. But no such studies has been done evaluating the link between endodontic infection and endothelial dysfunction using these markers.
Another commonly used non-invasive marker these days is Carotid Intima-media thickness (IMT). c-IMT is increasingly used as a surrogate end point of vascular outcomes in clinical trials aimed at determining the success of interventions that lower risk factors for atherosclerosis and associated diseases (stroke, myocardial infarction and peripheral artery diseases). This observer dependable technique, which serves both as an early detector and a follow up tool, provides information about common carotid (CCA), bifurcation, internal (ICA) and external carotid arteries. It has been established that abnormal baseline and rapid progressive CIMT are correlated to more cardiovascular and stroke events. Every 0.1 mm increase in the CIMT was associated with a 10-15% increase in the risk of myocardial infarction, and in the same line, a 13-18 % increase in stroke events. Many interventional and cross-sectional studies have shown the link between periodontitis and c-IMT.
No prospective observational trial, to the best of our knowledge, has been done till date depicting the link between endodontic infection and cardiovascular disease using FMD and c-IMT. The aim of the present study is to depict that endodontic infection is also one of the novel risk factor of CVD using a non-invasive techniques i.e. Flow mediated dilatation (FMD) and c-IMT.
AIMS AND OBJECTIVES To depict that Endodontic infection is associated with endothelial dysfuction by measuring flow mediated dilatation (FMD) of brachial artery and carotid intima media thickness (c-IMT) of common carotid artery.
MATERIALS AND METHODS
The present study will be done in the department of Radiology, PGIMS, Rohtak and Department of Cardiology, PGIMS, Rohtak.
Study subjects will be obtained from the pool of OPD patients in the Department of Conservative dentistry and Endodontics, PGIDS, Rohtak.
METHODOLOGY 35 patients who consecutively registered for a dental checkup at the OPD and fulfilled the previously mentioned criteria will be enrolled.
Additional 35 patients who were free from clinical and radiographic evidence of AP and met the inclusion and exclusion criteria of the study will be included as contols.
All individuals aged will underwent a complete CV assessment including medical history, physical examination, blood pressure measurement and 12-lead electrocardiogram.
A complete dental examination will be performed on each patient in both groups.
DENTAL EXAMINATION A panoramic radiograph will be examined and used as initial screening . It will be followed by selected periapical radiographs taken on teeth suspected of presenting AP and in all teeth with root canal treatments or presenting extensive restorations (including prosthetic restorations) with or without previous endodontic treatment.
Periapical radiographs were taken with a radiographic unit by using a long cone paralleling technique.
By using both radiographic and intraoral evaluations the following parameters were recorded:
1. Number of teeth present
2. Number and location of restored teeth
3. Number of endodontically treated teeth
4. Number and location of teeth affected by carious processes
5. Soft tissue assessment (presence and location of swelling/sinus tracts)
6. Periodontal probing
7. Number and location of teeth with AP
8. State of the upper and lower jaws Brachial Artery Assessment Patient preparation 1) Fast at least 8-12 hours before study. 2) Should not exercise, should not ingest substances like caffeine, high fat foods, vit C or tobacco at least 4-6 hours before study.
Clinical Procedure The diameter of the target artery (right brachial artery) was measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA).
Patient is placed in supine position with arm comfortably placed. Right brachial artery will be imaged above antecubital fossa in longitudinal plane.
In each study 4 scans will be taken:
Scan1 (At rest) The subject lay at rest for at least 10 min before a first resting scan will be recorded.
Then diameter of the artery will be measured from anterior to the posterior "m" line (the interface between intima media and intima adventitia)
Arterial flow velocity will be measured, by means of a pulsed doppler signal at a 70deg angle to the vessel in the centre of the artery.
Scan 2 (Endothelium dependent FMD) Increased flow was then induced by inflation of a pneumatic tourniquet to a pressure of at least 50 mm Hg above systolic pressure for 4-5 min (reactive hyperaemia).
A second scan was taken for 30 s before and 90 s after cuff deflation, including a repeat flow velocity recording for the first 15 s after cuff release.
Brachial Artery diameter will be taken 45-60 sec after cuff deflation.
Scan3 (Again at rest) At least 10 min of rest is needed after reactive hyperaemia before another image is acquired to reflect the re-established baseline conditions.
Third scan is taken at this point of time. Scan4 (Endothelium independent FMD) Then 0.4 mg of nitroglycerine (GTN) is given sublingually. (GTN will be omitted if the patient refuse or if the patient had a history of migraine headaches, systolic blood pressure \<100 mm Hg, previous adverse reaction to nitrates, or critical carotid artery stenosis) After 4 min fourth and final scan will be taken. Carotid intima-media thickness (c-IMT) Common carotid artery (CCA) will be used because of its convenience and high reproducibility.
c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position.
CCA will be scanned on longitudinal two-dimensional planes. Images will be obtained at the level of distal 1.0 cm of the right CCA. When an optimal image will be obtained, it was frozen on the R wave of the electro- cardiogram and stored on videotape.
For each segment, the c-IMT of the posterior wall will be measured automatically over 200 pixels with computer-assisted electronic callipers.
Maximal right CCA thickness will be measured and used for analysis. Primary Outcome variable The primary outcome variables observed for the study will be the difference in the FMD and c-IMT of the test group and control group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test group
Subjects having periapical disease diagnosed clinically and radiographically and free from any other systemic illness. FMD and c-IMT will be determined by ultrasound
FMD and c-IMT
The diameter of the target artery (right brachial artery) will be measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA).
c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position.
Control group
Healthy subject. FMD and c-IMT will be determined by ultrasound
FMD and c-IMT
The diameter of the target artery (right brachial artery) will be measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA).
c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FMD and c-IMT
The diameter of the target artery (right brachial artery) will be measured from two- dimensional ultrasound images, with a 70 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA).
c-IMT will be assessed by M-mode ultrasonography via a vivid 7 MHz linear array transducer and a standard 128XP/10 system (Acuson, Mountain View, California, USA) with participants in the supine position.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presence of apical periodontitis as assessed both clinically and radiographically (teeth with apical symptoms but without radiographic appearance of AP were not include).
* Presence of at least 25 teeth.
* Echocardiographic Left Ventricle Ejection Fraction (LVEF) value \>55%.
* Hepatic and renal function within normal limits (bilirubin\<1.5mg/dl; creatine\<2.0mg/dl).
Exclusion Criteria
* Presence of non-endodontic lesion in Maxilla/ mandible.
* Presence of cardiovascular risk factors(arterial hypertension, dyslipidemia, DM, obesity, smoking)
* LV hypertrophy at echocardiography previous or current CVD.
* Presence of chronic inflammatory conditions in other regions involving systemic health.
* For women, use of anticonceptive hormones.
* Systemic antibiotic treatment within the previous 3 months or any other regular medication.
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Postgraduate Institute of Dental Sciences Rohtak
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Post Graduate Institute of Dental Sciences
Rohtak, Haryana, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nishant
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.